Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 22.15 | 03:10:43 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 22.15 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 12.3202 - 32.10 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 22.15 | USD |
Cassava Sciences (SAVA) Options Flow Summary
Cassava Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.94M | 43.23M | - | 0 | -97.22M | -2.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cassava Sciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 20.68 | 22.50 | 20.17 | 21.97 | 824,543 | 1.47 | 7.11% |
| 1 Month | 19.72 | 26.6757 | 19.435 | 22.26 | 1,070,702 | 2.43 | 12.32% |
| 3 Months | 23.50 | 26.6757 | 18.18 | 21.90 | 778,441 | -1.35 | -5.74% |
| 6 Months | 20.50 | 32.10 | 18.18 | 23.64 | 947,022 | 1.65 | 8.05% |
| 1 Year | 23.02 | 32.10 | 12.3202 | 21.74 | 989,408 | -0.87 | -3.78% |
| 3 Years | 46.65 | 146.16 | 12.3202 | 49.57 | 2,368,059 | -24.50 | -52.52% |
| 5 Years | 1.12 | 146.16 | 1.00 | 34.36 | 2,789,976 | 21.03 | 1,877.68% |
Cassava Sciences Description
| Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. |
